Q4 2019 Holdings
Filed 2020-02-14 | 135 holdings | $257.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | ADR | 04351P101 | $154.4M | 1,109,874 | 59.9% |
| Biomarin Pharmaceutical Inc(BMRN) | COMM | 09061G101 | $37.4M | 441,872 | 14.5% |
| Coherus BioSciences(CHRS) | COMM | 19249H103 | $34.8M | 1,933,221 | 13.5% |
| Biogen Inc(BIIB) | COMM | 09062X103 | $18.9M | 63,711 | 7.3% |
| BioCryst Pharmaceuticals Inc(BCRX) | COMM | 09058V103 | $7.4M | 2,151,164 | 2.9% |
| Aclaris Therapeutics(ACRS) | COMM | 00461U105 | $3.6M | 1,911,573 | 1.4% |
| Nextcure, Inc | COMM | 65343E108 | $150.5K | 2,671,856 | 0.1% |
| Karuna Therapeutics, Inc. | COMM | 48576A100 | $142.1K | 1,885,602 | 0.1% |
| Amarin | ADR | 023111206 | $111.7K | 5,208,305 | 0.0% |
| Natera(NTRA) | COMM | 632307104 | $104.5K | 3,100,560 | 0.0% |
| Principia Biopharma(PRNB) | COMM | 74257L108 | $77.6K | 1,417,258 | 0.0% |
| Y-mAbs Therapeutics, Inc(YMABUSD) | COMM | 984241109 | $68.6K | 2,194,278 | 0.0% |
| Galera Therapeutics, Inc(GRTX) | COMM | 36338D108 | $40.6K | 3,083,712 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COMM | 92532F100 | $30.5K | 139,164 | 0.0% |
| Merus N.V. | COMM | N5749R100 | $27.6K | 1,961,039 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COMM | 69366J200 | $24.8K | 517,092 | 0.0% |
| Merck & Co Inc(MRK) | COMM | 58933Y105 | $21.9K | 240,806 | 0.0% |
| Regeneron Pharmaceuticals Inc(REGN) | COMM | 75886F107 | $18.8K | 50,086 | 0.0% |
| ObsEva SA | COMM | H5861P103 | $18.1K | 4,749,623 | 0.0% |
| United Therapeutics Corp(UTHR) | COMM | 91307C102 | $16.6K | 188,645 | 0.0% |
| ChemoCentryx Inc(CCXIEUR) | COMM | 16383L106 | $14.9K | 376,944 | 0.0% |
| Nucana Biomed Ltd | Ordinary Shares | GB00BYWYV | $14.6K | 2,400,000 | 0.0% |
| MyoKardia Inc | COMM | 62857M105 | $14.3K | 195,871 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COMM | 60468T105 | $14.0K | 108,383 | 0.0% |
| Nucana Biomed Ltd | ADR | 67022C106 | $13.8K | 2,266,666 | 0.0% |
| MacroGenics Inc(MGNX) | COMM | 556099109 | $12.8K | 1,173,882 | 0.0% |
| Fate Therapeutics Inc(FATE) | COMM | 31189P102 | $12.4K | 635,143 | 0.0% |
| Alnylam Pharmaceuticals IncCall | COMM | 02043Q907 | $11.5K | 100,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COMM | 803607100 | $11.3K | 87,818 | 0.0% |
| Kadmon Holdings Inc(KDMN) | COMM | 48283N106 | $10.7K | 2,368,958 | 0.0% |
| Kiniksa Pharmaceuticals, Ltd | COMM CL A | G5269C101 | $10.2K | 922,700 | 0.0% |
| Medicines CoPut | COMM | 584688955 | $9.3K | 110,000 | 0.0% |
| TG Therapeutics Inc(TGTX) | COMM | 88322Q108 | $9.0K | 811,292 | 0.0% |
| Calithera Biosciences Inc(CALAEUR) | COMM | 13089P101 | $8.3K | 1,458,821 | 0.0% |
| Dermira Inc(DERMEUR) | COMM | 24983L104 | $8.3K | 545,466 | 0.0% |
| Alexion Pharmaceuticals IncCall | COMM | 015351909 | $8.1K | 75,000 | 0.0% |
| Chiasma(CHMA) | COMM | 16706W102 | $8.1K | 1,630,221 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COMM | 00434H108 | $7.8K | 147,032 | 0.0% |
| Iterum Therapeutics | COMM | G6333L101 | $7.8K | 1,726,514 | 0.0% |
| ArQule Inc(ARQLUSD) | COMM | 04269E107 | $7.7K | 387,469 | 0.0% |
| Entasis Therapeutics Holdings Inc. | COMM | 293614103 | $5.9K | 1,180,178 | 0.0% |
| Otonomy Inc | COMM | 68906L105 | $5.8K | 1,515,629 | 0.0% |
| Seattle Genetics Inc | COMM | 812578102 | $5.7K | 50,000 | 0.0% |
| Forty Seven Inc(FTSVEUR) | COMM | 34983P104 | $5.5K | 138,643 | 0.0% |
| Zymeworks Inc | COMM | 98985W102 | $4.9K | 107,552 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COMM | 03152W109 | $4.6K | 475,330 | 0.0% |
| XBiotech Inc(XBIT) | COMM | 98400H102 | $4.5K | 240,995 | 0.0% |
| Orchard Therapeutics PLC | ADR | 68570P101 | $3.9K | 283,406 | 0.0% |
| Foamix Pharmaceuticals Ltd | COMM | M46135105 | $3.9K | 1,162,176 | 0.0% |
| Applied Therapeutics Inc(APLT) | COMM | 03828A101 | $3.7K | 134,825 | 0.0% |